Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

Antonino Glaviano, Hannah Lau, Lukas M. Carter, E. Hui Clarissa Lee, Hiu Yan Lam, Elena Okina, Daniel S.w. Tan, Wen Tan, Hui Li Ang, Daniela Carbone, Michelle Yi-Hui Yee, Muthu K. Shanmugam, Xiao Zi Huang, Gautam Sethi, Tuan Zea Tan, Lina H. K. Lim, Ruby Yun‐Ju Huang, Hendrik Ungefroren, Elisa Giovannetti, Dean G. Tang, Tullia C. Bruno, Peng Luo, Mads Hald Andersen, Bin‐Zhi Qian, Jun Ishihara, Derek C. Radisky, Stanton B. Elias, Saurabh Yadav, Minah Kim, Caroline Robert, Patrizia Diana, Kurt A. Schalper, Tao Shi, Taha Merghoub, Simone Krebs, Anjali P. Kusumbe, Matthew S. Davids, Jennifer Brown, Alan Prem KumarJournal of Hematology & Oncology 2025 · DOI

Abstract

The tumor microenvironment (TME) is integral to cancer progression, impacting metastasis and treatment response. It consists of diverse cell types, extracellular matrix components, and signaling molecules that interact to promote tumor growth and therapeutic resistance. Elucidating the intricate interactions between cancer cells and the TME is crucial in understanding cancer progression and therapeutic challenges. A critical process induced by TME signaling is the epithelial-mesenchymal transition (EMT), wherein epithelial cells acquire mesenchymal traits, which enhance their motility and invasiveness and promote metastasis and cancer progression. By targeting various components of the TME, novel investigational strategies aim to disrupt the TME's contribution to the EMT, thereby improving treatment efficacy, addressing therapeutic resistance, and offering a nuanced approach to cancer therapy. This review scrutinizes the key players in the TME and the TME's contribution to the EMT, emphasizing avenues to therapeutically disrupt the interactions between the various TME components. Moreover, the article discusses the TME's implications for resistance mechanisms and highlights the current therapeutic strategies toward TME modulation along with potential caveats.
BibTeX
@article{glaviano2025harnessing,
  author = {Antonino Glaviano and Hannah Lau and Lukas M. Carter and E. Hui Clarissa Lee and Hiu Yan Lam and Elena Okina and Daniel S.W. Tan and Wen Tan and Hui Li Ang and Daniela Carbone and Michelle Yi-Hui Yee and Muthu K. Shanmugam and Xiao Zi Huang and Gautam Sethi and Tuan Zea Tan and Lina H. K. Lim and Ruby Yun‐Ju Huang and Hendrik Ungefroren and Elisa Giovannetti and Dean G. Tang and Tullia C. Bruno and Peng Luo and Mads Hald Andersen and Bin‐Zhi Qian and Jun Ishihara and Derek C. Radisky and Stanton B. Elias and Saurabh Yadav and Minah Kim and Caroline Robert and Patrizia Diana and Kurt A. Schalper and Tao Shi and Taha Merghoub and Simone Krebs and Anjali P. Kusumbe and Matthew S. Davids and Jennifer Brown and Alan Prem Kumar},
  title = {{Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition}},
  journal = {Journal of Hematology \& Oncology},
  year = {2025},
  doi = {10.1186/s13045-024-01634-6},
}

Loading related content...

Figure